Gene Delivery System Industry Research Report 2024

Gene Delivery System Industry Research Report 2024


Summary

According to APO Research, The global Gene Delivery System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Gene Delivery System is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Gene Delivery System is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Gene Delivery System is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Gene Delivery System include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and bluebird bio, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gene Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Delivery System.
The Gene Delivery System market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Gene Delivery System segment by Type

Viral Gene Delivery System
Non-viral Gene Delivery System
Gene Delivery System segment by Application

Neurological Diseases
Cancer
Others
Gene Delivery System Segment by Region

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Delivery System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gene Delivery System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Delivery System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Gene Delivery System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Gene Delivery System by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Viral Gene Delivery System
2.2.3 Non-viral Gene Delivery System
2.3 Gene Delivery System by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Neurological Diseases
2.3.3 Cancer
2.3.4 Others
2.4 Assumptions and Limitations
3 Gene Delivery System Breakdown Data by Type
3.1 Global Gene Delivery System Historic Market Size by Type (2019-2024)
3.2 Global Gene Delivery System Forecasted Market Size by Type (2025-2030)
4 Gene Delivery System Breakdown Data by Application
4.1 Global Gene Delivery System Historic Market Size by Application (2019-2024)
4.2 Global Gene Delivery System Forecasted Market Size by Application (2019-2024)
5 Global Growth Trends
5.1 Global Gene Delivery System Market Perspective (2019-2030)
5.2 Global Gene Delivery System Growth Trends by Region
5.2.1 Global Gene Delivery System Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Gene Delivery System Historic Market Size by Region (2019-2024)
5.2.3 Gene Delivery System Forecasted Market Size by Region (2025-2030)
5.3 Gene Delivery System Market Dynamics
5.3.1 Gene Delivery System Industry Trends
5.3.2 Gene Delivery System Market Drivers
5.3.3 Gene Delivery System Market Challenges
5.3.4 Gene Delivery System Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Gene Delivery System Players by Revenue
6.1.1 Global Top Gene Delivery System Players by Revenue (2019-2024)
6.1.2 Global Gene Delivery System Revenue Market Share by Players (2019-2024)
6.2 Global Gene Delivery System Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Gene Delivery System Head office and Area Served
6.4 Global Gene Delivery System Players, Product Type & Application
6.5 Global Gene Delivery System Players, Date of Enter into This Industry
6.6 Global Gene Delivery System Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Gene Delivery System Market Size (2019-2030)
7.2 North America Gene Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Gene Delivery System Market Size by Country (2019-2024)
7.4 North America Gene Delivery System Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe Gene Delivery System Market Size (2019-2030)
8.2 Europe Gene Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Gene Delivery System Market Size by Country (2019-2024)
8.4 Europe Gene Delivery System Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Gene Delivery System Market Size (2019-2030)
9.2 Asia-Pacific Gene Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Gene Delivery System Market Size by Country (2019-2024)
9.4 Asia-Pacific Gene Delivery System Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 Latin America
10.1 Latin America Gene Delivery System Market Size (2019-2030)
10.2 Latin America Gene Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Gene Delivery System Market Size by Country (2019-2024)
10.4 Latin America Gene Delivery System Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Gene Delivery System Market Size (2019-2030)
11.2 Middle East & Africa Gene Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Gene Delivery System Market Size by Country (2019-2024)
11.4 Middle East & Africa Gene Delivery System Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 Players Profiled
12.1 Biogen
12.1.1 Biogen Company Information
12.1.2 Biogen Business Overview
12.1.3 Biogen Revenue in Gene Delivery System Business (2019-2024)
12.1.4 Biogen Gene Delivery System Product Portfolio
12.1.5 Biogen Recent Developments
12.2 Novartis
12.2.1 Novartis Company Information
12.2.2 Novartis Business Overview
12.2.3 Novartis Revenue in Gene Delivery System Business (2019-2024)
12.2.4 Novartis Gene Delivery System Product Portfolio
12.2.5 Novartis Recent Developments
12.3 Gilead Sciences
12.3.1 Gilead Sciences Company Information
12.3.2 Gilead Sciences Business Overview
12.3.3 Gilead Sciences Revenue in Gene Delivery System Business (2019-2024)
12.3.4 Gilead Sciences Gene Delivery System Product Portfolio
12.3.5 Gilead Sciences Recent Developments
12.4 Sarepta Therapeutics
12.4.1 Sarepta Therapeutics Company Information
12.4.2 Sarepta Therapeutics Business Overview
12.4.3 Sarepta Therapeutics Revenue in Gene Delivery System Business (2019-2024)
12.4.4 Sarepta Therapeutics Gene Delivery System Product Portfolio
12.4.5 Sarepta Therapeutics Recent Developments
12.5 Alnylam Pharmaceuticals
12.5.1 Alnylam Pharmaceuticals Company Information
12.5.2 Alnylam Pharmaceuticals Business Overview
12.5.3 Alnylam Pharmaceuticals Revenue in Gene Delivery System Business (2019-2024)
12.5.4 Alnylam Pharmaceuticals Gene Delivery System Product Portfolio
12.5.5 Alnylam Pharmaceuticals Recent Developments
12.6 Amgen
12.6.1 Amgen Company Information
12.6.2 Amgen Business Overview
12.6.3 Amgen Revenue in Gene Delivery System Business (2019-2024)
12.6.4 Amgen Gene Delivery System Product Portfolio
12.6.5 Amgen Recent Developments
12.7 Spark Therapeutics
12.7.1 Spark Therapeutics Company Information
12.7.2 Spark Therapeutics Business Overview
12.7.3 Spark Therapeutics Revenue in Gene Delivery System Business (2019-2024)
12.7.4 Spark Therapeutics Gene Delivery System Product Portfolio
12.7.5 Spark Therapeutics Recent Developments
12.8 Akcea Therapeutics
12.8.1 Akcea Therapeutics Company Information
12.8.2 Akcea Therapeutics Business Overview
12.8.3 Akcea Therapeutics Revenue in Gene Delivery System Business (2019-2024)
12.8.4 Akcea Therapeutics Gene Delivery System Product Portfolio
12.8.5 Akcea Therapeutics Recent Developments
12.9 bluebird bio
12.9.1 bluebird bio Company Information
12.9.2 bluebird bio Business Overview
12.9.3 bluebird bio Revenue in Gene Delivery System Business (2019-2024)
12.9.4 bluebird bio Gene Delivery System Product Portfolio
12.9.5 bluebird bio Recent Developments
12.10 Sunway Biotech
12.10.1 Sunway Biotech Company Information
12.10.2 Sunway Biotech Business Overview
12.10.3 Sunway Biotech Revenue in Gene Delivery System Business (2019-2024)
12.10.4 Sunway Biotech Gene Delivery System Product Portfolio
12.10.5 Sunway Biotech Recent Developments
12.11 SIBIONO
12.11.1 SIBIONO Company Information
12.11.2 SIBIONO Business Overview
12.11.3 SIBIONO Revenue in Gene Delivery System Business (2019-2024)
12.11.4 SIBIONO Gene Delivery System Product Portfolio
12.11.5 SIBIONO Recent Developments
12.12 AnGes
12.12.1 AnGes Company Information
12.12.2 AnGes Business Overview
12.12.3 AnGes Revenue in Gene Delivery System Business (2019-2024)
12.12.4 AnGes Gene Delivery System Product Portfolio
12.12.5 AnGes Recent Developments
12.13 Orchard Therapeutics
12.13.1 Orchard Therapeutics Company Information
12.13.2 Orchard Therapeutics Business Overview
12.13.3 Orchard Therapeutics Revenue in Gene Delivery System Business (2019-2024)
12.13.4 Orchard Therapeutics Gene Delivery System Product Portfolio
12.13.5 Orchard Therapeutics Recent Developments
12.14 Human Stem Cells Institute
12.14.1 Human Stem Cells Institute Company Information
12.14.2 Human Stem Cells Institute Business Overview
12.14.3 Human Stem Cells Institute Revenue in Gene Delivery System Business (2019-2024)
12.14.4 Human Stem Cells Institute Gene Delivery System Product Portfolio
12.14.5 Human Stem Cells Institute Recent Developments
13 Report Conclusion
14 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings